Multiple Metabolic Syndrome: Aspects of Genetic Epidemiology and Molecular Genetics

References

• Kannel W B., Neaton J D., Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325, 348 men screened for MRFIT. Am Heart J 1986; 112: 825–36
   PubMed Web of Science ®Google Scholar
• Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis 1978; 31: 201–306
   PubMedGoogle Scholar
• Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131–41
   PubMedGoogle Scholar
• Ducimentiere P, Eschwege E, Papoz L, et al. Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease. Diabetologia 1980; 19: 205–10
   Google Scholar
• Björntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand Suppl 1988; 723: 121–34
   PubMedGoogle Scholar
• Björntorp P. ‘Portal’ adipose tissue as a generator of risk factors of cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493–6
   PubMedGoogle Scholar
• MacMahon S W., Macdonald G J., Blacket R B. Plasma lipoprotein levels in treated and untreated hypertensive men and women. Arteriosclerosis 1985; 5: 391–6
   PubMedGoogle Scholar
• Williams R R., Hunt S C., Hopkins P N., et al. Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988; 259: 3579–86
   PubMed Web of Science ®Google Scholar
• Austin M A., King M-C, Vranizan K M., Krauss R M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495–506
   PubMed Web of Science ®Google Scholar
• Barnett A H., Leslie R DG, Pyke D A. Twin studies in non-insulin-dependent diabetes. The genetics of diabetes mellitus, J Köbberling, R Tattersall. Academic Press, London 1982; 225–32
   Google Scholar
• Reaven G M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
   PubMed Web of Science ®Google Scholar
• Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557–63
   PubMed Web of Science ®Google Scholar
• Utermann G, Kindermann I, Kaffarnik H, et al. Apolipo-protein E phenotypes and hyperlipidaemia. Hum Genet 1984; 65: 232–6
   PubMedGoogle Scholar
• Lilja M K., Kervinen K, Jounela A J., Koistinen J, Kesäniemi Y A. Apolipoprotein E polymorphism in hypertensive patients: Gene frequencies, plasma lipids and relation to antihypertensive drugs. Circulation 1989; 80: 285
   PubMedGoogle Scholar
• Lenzen H J., Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986; 32: 778–81
   PubMed Web of Science ®Google Scholar
• Laakso M, Kesäniemi A, Kervinen K, Jauhiainen M, Pyörälä K. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin-dependent diabetes. Br Med J 1991; 303: 1159–62
   PubMed Web of Science ®Google Scholar
• Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–38
   PubMed Web of Science ®Google Scholar
• Middeke M, Richter W O., Schwandt P, Beck B, Holzgreve H. Normalization of lipid metabolism after withdrawal from antihypertensive long-term therapy with beta blockers and diuretics. Arteriosclerosis 1990; 10: 145–7
   PubMedGoogle Scholar
• Kesäniemi Y A., Lilja M, Kervinen K, Juustila H. Reduced low-density lipoprotein apoprotein B transport by a calcium antagonist, diltiazem, in patients with hypertension. Circulation 1991; 84: 4, 481
   Google Scholar